Steris and Camden Property Trust Valuations in Focus Amid Fed Policy Outlook

Key Facts

1Steris shares closed at approximately $215 with a trailing P/E of 26.8 and a dividend yield of 1.2%.

2Steris guidance for fiscal year 2027 EPS ranges from $11.10 to $11.30.

3Camden Property Trust investors are monitoring U.S. Treasury yields and Fed policy to assess REIT performance.

As investors re-evaluate valuation multiples across the healthcare and real estate sectors, operational metrics are being weighed against broader macroeconomic shifts. Steris (STE) shares closed at approximately $106.56, reflecting a trailing P/E ratio of 26.8 and a dividend yield of 1.2%. Meanwhile, the company has issued EPS guidance for fiscal year 2027 in the range of $11.10 to $11.30, as Camden Property Trust (CPT) investors closely monitor U.S. Treasury yields and Federal Reserve policy to gauge REIT performance.

Comparing peer valuations in medical equipment, Stryker (SYK) trades at a forward P/E of approximately 25.5 per market data, placing Steris's valuation in line with industry leaders. In the residential REIT space, Camden has faced headwinds from elevated financing costs; notably, the S&P/Case-Shiller Home Price Index released on May 26, 2026, showed a 0.8% YoY increase, missing the 1% forecast and signaling a cooling trend in the broader housing market.

Traders are currently watching support levels for STE near the $210 mark based on price action at close May 29, 2026. Looking ahead, upcoming inflation and growth data will be critical catalysts for interest rate expectations, especially after U.S. GDP growth was reported at 1.6% on May 28, 2026, a figure that directly impacts borrowing costs for CPT and the discounted cash flow valuations for the sector.